News UK launches its 'Netflix-style' payment model for antibiotic... The UK is poised to become the first country in the world to launch a new payment model for antibiotics that could reverse decades of decline in the category.
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.